ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2026 Pediatric Rheumatology Symposium

March 18-21, 2026. Minneapolis, MN.

View by Number View by Title View Sessions
  • Abstract Number: 122

    Assessing the Relationship Between Multidimensional Area Level Indicators and Lupus Disease Activity in Children
  • Abstract Number: 123

    The Details Matter: A Patient Centered Approach to Overcoming Barriers in a Pediatric to Adult Rheumatology Transition Clinic
  • Abstract Number: 124

    Patient perspectives, barriers, and next steps in a health care transition clinic for pediatric to adult rheumatology
  • Abstract Number: 125

    Educational Interventions to Increase Transition Preparedness in a Pediatric Rheumatology Clinic
  • Abstract Number: 126

    Unmet Social Needs in Pediatric Rheumatic Disease: A Study of Disparities
  • Abstract Number: 127

    Setting the Stage for an Effective, Accessible, and Patient-Centered Nature-Based Intervention for Adolescents with Juvenile Idiopathic Arthritis (JIA)
  • Abstract Number: 128

    Trends in Medicaid Enrollment Churn Among Children with Rheumatic Disease Diagnoses, 2018-2023
  • Abstract Number: 129

    Selection of Core Measures in Development of a Childhood Arthritis and Rheumatology Research Alliance based Pediatric Pain Registry for Management of Amplified Musculoskeletal Pain Syndrome
  • Abstract Number: 130

    Resilience, Cumulative Social Disadvantage, and Disease Activity in Juvenile Idiopathic Arthritis (JIA)
  • Abstract Number: 131

    Reflections on the Creation of a Transition Clinic and the First 6-months of a Registry for Young Adults with Juvenile Idiopathic Arthritis: The Women’s College Hospital Experience
  • Abstract Number: 132

    AI-Assisted Body-Region Recognition for Localized Scleroderma: the 1st Step in Automated LoSCAT scoring
  • Abstract Number: 133

    Pathologic Lymphangiogenesis in Mouse Model and Patients with Pulmonary Arterial Hypertension
  • Abstract Number: 134

    More Than Meets the Eye: Broadening the Clinical Spectrum of RelA Haploinsufficiency
  • Abstract Number: 135

    The Blood-CSF-Barrier in SLE: Volume and Blood Flow of the Choroid Plexus and Periventricular Tissue Abnormality Gradients
  • Abstract Number: 136

    Transcriptomic Analysis of Ultrasound-Guided Synovial Biopsies from Patients with Juvenile Idiopathic Arthritis
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology